Tuesday, 8 December 2020

Fluorescein Angiography Market Size, Share, Demand, Future Growth Insights And Trends

The global fluorescein angiography market size is expected to reach USD 617.4 million by the end of 2027, expanding at a CAGR of 2.7%, according to a new report by Grand View Research, Inc. Increasing prevalence of ophthalmic conditions such as macular degeneration and diabetic retinopathy and rapid technological advancements are some of the high impact-rendering market drivers. However, the growing preference for safer and faster alternatives such as OCT and fundus autofluorescence is anticipated to impede market growth during the forecast period.

End-users such as hospitals and imaging centers in the country are effectively adopting AI-based fundus cameras for detecting various blindness-causing diseases. For instance, in January 2019, Deqing County hospital in Guangdong Province conducted a free consultation by featuring an AI camera codeveloped by Sun Yat-sen University and Baidu-a multinational technology company in China that offers services, including a search engine platform-to detect ocular fundus diseases. This AI fundus camera is capable of diagnosing glaucoma, diabetic retinopathy, and macular degeneration.

Despite preference of its alternatives, fluorescein angiography is often used as confirmatory test for a wide range of ophthalmic conditions. The technique provides accurate and high quality pictures which help in selecting efficient treatment regimen. In addition, the demand for tradition fluorescein angiography systems is still high in developing countries. This can be attributed to affordability and product availability.

Full Research Report On Fluorescein Angiography Market Visit Here: https://www.grandviewresearch.com/industry-analysis/fluorescein-angiography-market

Fluorescein Angiography Market Report Highlights

  • North America accounted for the largest share in 2019 owing to favorable reimbursement policies, high adoption rate of advanced technologies, and increasing prevalence of diabetic retinopathy
  • By product, the market is segmented into devices, disposables, and accessories
  • The devices segment captured the largest market size in 2019 and is expected to witness a CAGR of 3.0% over the forecast period
  • Availability of hybrid devices and technological advancements such as auto-focus and integration with AI are major factors driving the devices segment
  • Based on application, the market is segmented into macular edema, macular degeneration, macular pucker, ocular melanoma, diabetic retinopathy, and others
  • Macular degeneration and diabetic retinopathy captured the largest market share in 2019

Request a Sample Copy of the Report @ https://www.grandviewresearch.com/industry-analysis/fluorescein-angiography-market/request/rs1

Fluorescein Angiography Market Segmentation

Grand View Research has segmented the global fluorescein angiography market based on product, technology, application, and region:

Fluorescein Angiography Product Outlook (Revenue, USD Million, 2016 - 2027)

  • Device
  • Disposables
    • Dye
    • Film
  • Accessories

Fluorescein Angiography Technology Outlook (Revenue, USD Million, 2016 - 2027)

  • Digital
  • Analog

Fluorescein Angiography Application Outlook (Revenue, USD Million, 2016 - 2027)

  • Macular edema
  • Macular degeneration
  • Macular pucker
  • Ocular melanoma
  • Diabetic retinopathy
  • Others

Fluorescein Angiography Regional Outlook (Revenue, USD Million, 2016 - 2027)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Russia
  • Asia Pacific
    • Japan
    • China
    • India
    • Malaysia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Qatar

List of Key Players of Fluorescein Angiography Market

  • Carl Zeiss Meditec, Inc.
  • NIDEK Co., Ltd.
  • Kowa Company Ltd.
  • Topcon Medical Systems, Inc.
  • Optomed Oy (Ltd.)
  • CenterVue SpA
  • Canon, Inc.

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

No comments:

Post a Comment